How do people with neurofibromatosis type 1 (the forgotten victims) live? A grounded theory study - Foji S, Mohammadi E, Sanagoo A, Jouybari L.
BACKGROUND: Neurofibromatosis type I (NF1) is a rare genetic disorder, associated with some physical symptoms including spots and tiny bumps on the skin, and internal organ involvement. People suffering from neurofibromatosis face various challenges in the... (Source: SafetyLit)
Source: SafetyLit - January 27, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Increased Dosing Can Benefit Overweight Patients With Psoriasis Increased Dosing Can Benefit Overweight Patients With Psoriasis
' Weight may have an impact on pharmacokinetics and, therefore, on the clinical outcome of biologic treatment for psoriasis, ' the authors commented.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 27, 2022 Category: Rheumatology Tags: Dermatology News Source Type: news

A Newly Published Network Meta-Analysis (NMA) Found TREMFYA ® (guselkumab) Ranked Highest for Overall Level of Skin Clearance and Provided Positive Joint Efficacy Among Active Psoriatic Arthritis (PsA) Therapies
Conclusions (i.e., comparable) are based on an overlap of pairwise 95 percent credible intervals.1c. PASI 90 is defined as at least 90 percent improvement from baseline in the PASI score. The PASI score grades the amount of surface area on each body region that is covered by PsO plaques and the severity of plaques for their redness, thickness, and scaliness.13 PASI 90 was not a controlled endpoint in DISCOVER-1 or -2.8,9d. TREMFYA q4w dosing is not currently FDA-approved.2e. The PsA-modified vdH-S score combines erosion and joint space narrowing scores derived from radiographs of joints in body regions impacted by PsA.14 T...
Source: Johnson and Johnson - January 26, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Self - Help Aids Quality of Life for People With Psoriasis
Findings show modest, but significant, benefit from either compassion - based or mindfulness - based self - help (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 25, 2022 Category: Psychiatry Tags: Dermatology, Psychiatry, Journal, Source Type: news

Omicron Lives Longer on Plastic, Skin Than Other COVID Variants Omicron Lives Longer on Plastic, Skin Than Other COVID Variants
In a lab experiment, samples of different variants were applied to pieces of plastic and human skin collected from autopsies. A variant"survived" until it could no longer be detected on the surface.WebMD Health News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - January 25, 2022 Category: Pediatrics Tags: Infectious Diseases News Source Type: news

Johnson & Johnson Reports Q4 and Full-Year 2021 Results
New Brunswick, N.J. (January 25, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. “Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers” said Joaquin Duato, Chief Executive Officer. “Given our strong results, financial profile, and innovative pipeline we are well positioned for success in 2022 and beyond.” OVERALL FINANCIAL RESULTS ...
Source: Johnson and Johnson - January 25, 2022 Category: Pharmaceuticals Tags: Financial Source Type: news

Black Patients More Likely to Have Negative Descriptors in Notes
Compared with White patients, Black patients have 2.54 times the odds of having at least one negative descriptor in EHR (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 25, 2022 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Psy Source Type: news

What Are Common Gastrointestinal Polyposes in Children?
Discussion Bloody stools or blood in the diaper is a relatively common complaint in general pediatrics. For most patients it is often a minor concern. Commonly it is a transient problem (e.g. rectal fissure caused by constipation or trauma) or often not blood (e.g. urate crystals in the diaper, food, menses, etc.). Real blood does occur with an identifiable cause such as long distance running or heavy exercise, or milk protein allergy/sensitivity that improves with a milk-restricted diet. Many more serious causes are associated with heavier or more recalcitrant bleeding, increased defecation, abdominal pain, poor eating an...
Source: - January 24, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis
The approval is the second indication for the anti-interleukin 23 monoclonal antibody after approval for plaque psoriasis was granted in 2019.News Alerts (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 23, 2022 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Mayo Clinic Minute: Moisturizer tips from a dermatologist
(Source: Full Feed)
Source: Full Feed - January 22, 2022 Category: Consumer Health News Source Type: news

Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
Increased market growth of biosimilars that are similar to brand - name biologic agents has the potential to reduce spending on prescription drugs (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 21, 2022 Category: Cancer & Oncology Tags: Dermatology, Endocrinology, Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Oncology, Ophthalmology, Pharmacy, Rheumatology, Journal, Source Type: news

When the Patient Wants to Speak to a Manager When the Patient Wants to Speak to a Manager
' With virus variants raging, inflation growing, and call center wait times approaching infinity, many of our patients, it seems, cannot bear any more, ' Dr Jeffrey Benabio writes in his column.Medscape Dermatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 21, 2022 Category: Rheumatology Tags: Dermatology Commentary Source Type: news

More Than a Month After Launch, iPLEDGE Glitches Persist More Than a Month After Launch, iPLEDGE Glitches Persist
The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group (IPMG), the manufacturers responsible for the FDA-mandated REMS program.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 21, 2022 Category: Consumer Health News Tags: Dermatology News Source Type: news

POCUS on par with x-ray for COVID-19 diagnosis, management
Point-of-care ultrasound (POCUS) for lung imaging is noninferior to chest x-ra...Read more on AuntMinnie.comRelated Reading: Use of ultrasound contrast lags, despite its clear benefits Ultrasound fetal monitoring takes time for maternity nurses Ultrasound has tradeoffs for detecting skin cancer metastases Ultrasound best in margin assessment for breast surgery Should breast ultrasound scans after COVID vaccines be postponed? (Source: Headlines)
Source: Headlines - January 21, 2022 Category: Radiology Source Type: news

Verily and L ’Oréal team up on skin research, new digital tools
The pair will research how aging and the environment impact skin, and develop new digital diagnostic tools for dermatology.   (Source: mobihealthnews)
Source: mobihealthnews - January 20, 2022 Category: Information Technology Source Type: news